Literature DB >> 7726627

Proinflammatory properties of molluscum bodies.

H Takematsu1, H Tagami.   

Abstract

Molluscum contagiosum, a condition characterized by benign viral tumours, occasionally becomes inflamed and regresses spontaneously, an event probably initiated by a host cell-mediated immune rejection against the lesion, but it inevitably involves the disruption of the epidermal tissue to expose the molluscum bodies to the tissue fluids of the dermis. It has been suggested that the molluscum bodies induce inflammation by a mechanism similar to that involved in ruptured epidermal cysts or in acne. Despite the occasional development of inflammation in molluscum contagiosum, the proinflammatory properties of molluscum bodies have never been studied in vitro. Thus, in the present study we sought to determine whether molluscum bodies exert a proinflammatory effect by inducing neutrophil chemotaxis. When exposed to fresh serum in vitro, water-insoluble components of molluscum bodies activated the alternative complement pathway to produce chemotactic C5a/C5a des Arg. We also found that an aqueous extract of molluscum bodies exerted potent chemotactic activity for neutrophils. Remarkably high amounts of the immunoreactive proinflammatory cytokines IL-8 and GRO alpha were present in the extract even when compared with psoriatic scale extracts. Gel filtration HPLC of the extract demonstrated the presence of neutrophil chemotactic activity over a wide range of molecular mass. These data suggest that disruption of the epidermal wall of molluscum bodies induces acute inflammatory changes by activation of the alternative complement pathway on exposure to the tissue fluids, and that the molluscum bodies themselves release proinflammatory cytokines and other neutrophil chemotactic factors on decomposition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726627     DOI: 10.1007/bf00370727

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  26 in total

1.  Molluscum contagiosum, verruca and zoster viruses. Electron microscopic studies in the skin.

Authors:  M A LUTZNER
Journal:  Arch Dermatol       Date:  1963-04

2.  Molluscum contagiosum. A clinicopathologic study.

Authors:  A H MEHREGAN
Journal:  Arch Dermatol       Date:  1961-07

3.  Experimental inoculation of humans with ectodermotropic viruses.

Authors:  H GOLDSCHMIDT; A M KLIGMAN
Journal:  J Invest Dermatol       Date:  1958-09       Impact factor: 8.551

4.  Generation of NAP-1 and related peptides in psoriasis and other inflammatory skin diseases.

Authors:  J M Schröder
Journal:  Cytokines       Date:  1992

5.  Stratum corneum activation of complement through the antibody-independent alternative pathway.

Authors:  T Terui; T Kato; H Tagami
Journal:  J Invest Dermatol       Date:  1989-04       Impact factor: 8.551

6.  Spontaneous regression of plane warts after inflammation: clinical and histologic studies in 25 cases.

Authors:  H Tagami; M Takigawa; A Ogino; S Imamura; S Ofugi
Journal:  Arch Dermatol       Date:  1977-09

7.  Severe atypical molluscum contagiosum infection in an immunocompromised host.

Authors:  D W Cotton; C Cooper; D F Barrett; B J Leppard
Journal:  Br J Dermatol       Date:  1987-06       Impact factor: 9.302

8.  Molluscum dermatitis.

Authors:  H F Kipping
Journal:  Arch Dermatol       Date:  1971-01

9.  Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol       Date:  1993-01

10.  Molluscum contagiosum and the acquired immunodeficiency syndrome: clinical and immunological details of two cases.

Authors:  M Katzman; J T Carey; C A Elmets; G H Jacobs; M M Lederman
Journal:  Br J Dermatol       Date:  1987-01       Impact factor: 9.302

View more
  1 in total

1.  Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2.

Authors:  M D Krathwohl; R Hromas; D R Brown; H E Broxmeyer; K H Fife
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.